Medartis Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Public

  • Employees
  • 1,428

Employees

  • Stock Symbol
  • MED

Stock Symbol

  • Investments
  • 10

  • Share Price
  • $135.25
  • (As of Friday Closing)

Medartis General Information

Description

Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • Hochbergerstrasse 60 East
  • 4057 Basel
  • Switzerland
+41 061
Primary Industry
Therapeutic Devices
Other Industries
Surgical Devices
Stock Exchange
SWX
Corporate Office
  • Hochbergerstrasse 60 East
  • 4057 Basel
  • Switzerland
+41 061

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medartis Stock Performance

As of 20-Nov-2026, Medartis’s stock price is $135.25. Its current market cap is $1.68B with 12.4M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$135.25 $136.09 $87.18 - $136.91 $1.68B 12.4M 14.6K $1.51

Medartis Financials Summary

As of 30-Jun-2026, Medartis has a trailing 12-month revenue of $387M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,430,081 1,392,357 846,335 1,245,398
Revenue 386,901 323,973 255,342 235,845
EBITDA 64,303 53,427 32,774 27,862
Net Income 18,804 10,046 4,007 689
Total Assets 755,134 707,044 509,071 416,142
Total Debt 256,552 199,162 133,669 32,055
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Medartis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Medartis‘s full profile, request access.

Request a free trial

Medartis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFi
Therapeutic Devices
Basel, Switzerland
1,428 As of 2026

Princeton, NJ
 

Holland, MI
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Medartis Competitors (4)

One of Medartis’s 4 competitors is Integra LifeSciences Holdings, a Corporation company based in Princeton, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Integra LifeSciences Holdings Corporation Princeton, NJ
Shoulder Innovations Venture Capital-Backed Holland, MI
Orthofix Medical Formerly PE-Backed Lewisville, TX
Zimmer Biomet Holdings Corporation Warsaw, IN
To view Medartis’s complete competitors history, request access »

Medartis Patents

Medartis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4792760-A1 Bone plate and system for treating a fracture of a cavicula and/or tears of coracco-clavicular, coracco-acromial, and/or acromio-clavicular tapes Pending 12-Feb-2025
WO-2026171393-A1 Bone plate, system, and method for treating a fracture of the clavicle and/or tears of the coracoclavicular, coracoacromial, and/or acromioclavicular ligaments Pending 12-Feb-2025
US-20250082378-A1 Fibular nail outrigger surgical device Pending 13-Sep-2023
US-20240293118-A1 Compression fastener, instruments and methods Inactive 02-Mar-2023
US-12496108-B2 Orthopedic fasteners, instruments and methods Active 30-Dec-2022 A61B17/8052
To view Medartis’s complete patent history, request access »

Medartis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medartis Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Medartis‘s full profile, request access.

Request a free trial

Medartis Investments & Acquisitions (10)

Medartis’s most recent deal was a Merger/Acquisition with Miami Anatomical Research Center. The deal was made on 17-Sep-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Miami Anatomical Research Center 17-Sep-2026 Merger/Acquisition Other Healthcare Services
CADskills 14-May-2026 Merger/Acquisition Therapeutic Devices
KeriMedical 11-Jul-2025 Merger/Acquisition Therapeutic Devices
Neoortho 29-Apr-2025 Merger/Acquisition Surgical Devices
In2Bones (Avenger Radial Head Prosthesis System in Memphis, Tennessee) 27-Mar-2025 Corporate Asset Purchase Buildings and Property
You’re viewing 5 of 10 investments and acquisitions. Get the full list »

Medartis ESG

Risk Overview

Risk Rating

Updated November, 08, 2026

26.07 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view Medartis’s complete esg history, request access »

Medartis Affiliates

Subsidiaries (4)

Name Industry Location Year Founded
CADskills Gent, Belgium 2016
KeriMedical Plan-les-Ouates, Switzerland 2016
Miami Anatomical Research Center Doral, FL 2008
Neoortho Curitiba, Brazil 2004

Medartis FAQs

  • When was Medartis founded?

    Medartis was founded in 1997.

  • Where is Medartis headquartered?

    Medartis is headquartered in Basel, Switzerland.

  • What is the size of Medartis?

    Medartis has 1,428 total employees.

  • What industry is Medartis in?

    Medartis’s primary industry is Therapeutic Devices.

  • Is Medartis a private or public company?

    Medartis is a Public company.

  • What is Medartis’s stock symbol?

    The ticker symbol for Medartis is MED.

  • What is the current stock price of Medartis?

    As of 20-Nov-2026 the stock price of Medartis is $135.25.

  • What is the current market cap of Medartis?

    The current market capitalization of Medartis is $1.68B.

  • What is Medartis’s current revenue?

    The trailing twelve month revenue for Medartis is $387M.

  • Who are Medartis’s competitors?

    Integra LifeSciences Holdings, Shoulder Innovations, Orthofix Medical, and Zimmer Biomet Holdings are competitors of Medartis.

  • What is Medartis’s annual earnings per share (EPS)?

    Medartis’s EPS for 12 months was $1.51.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process